Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Cited by (1,029)

Items 501–600 of 1,029

1. β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase
   Anantharaman Muthuswamy, Jitbanjong Tangpong, Jeffrey N. Keller, Michael P. Murphy, William R. Markesbery, Kelley K. Kiningham, Daret K. St. Clair · 2006 · American Journal Of Pathology
2. Binding of Aβ to α- and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC
   Poul Henning Jensen, Peter Højrup, Henrik Hager, Morten Schallburg Nielsen, Linda JACOBSEN, Ole Frilev Olesen, Jørgen Gliemann, Ross Jakes · 1997 · Biochemical Journal
3. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A amyloid pathway
   Colin Louis Masters, Konrad Beyreuther · 2006 · Brain
4. ole of apoE/Aβ Interactions in the Pathogenesis of Alzheimer's Disease and Cerebral Amyloid Angiopathy
   Holtzman, David M. · 2001 · Journal of Molecular Neuroscience
5. RNA sequestration to pathological lesions of neurodegenerative diseases
   Stephen D. Ginsberg, James E. Galvin, Tsz-Ling Shirley Chiu, Virginia M.‐Y. Lee, Eliezer Masliah, John Q. Trojanowski · 1998 · Acta Neuropathologica
6. An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
   Keliang Pang, Richeng Jiang, Wei Zhang, Zhengyi Yang, Linlin Li, Makoto Shimozawa, Simone Tambaro, Johanna Mayer, Baogui Zhang, Man Li et al. · 2021 · Cell Research
7. Alzheimer's Disease and the Amyloid β Protein
   David Henry Small, Catriona McLean · 1999 · Journal of Neurochemistry
8. Basic FGF attenuates amyloid β-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons
   Mark, Robert J, Keller, Jeffrey N, Kruman, Inna, Mattson, Mark P · 1997 · Brain Research
9. Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models
   Marc Aurel Busche, Christine Grienberger, Aylin D. Keskin, Beomjong Song, Ulf Neumann, Matthias Staufenbiel, Hans Förstl, Arthur Konnerth · 2015 · Nature Neuroscience
10. The role of astrocytes in amyloid β-protein toxicity and clearance
    Dietmar Rudolf Thal · 2012 · Experimental Neurology
11. Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
    Scott J. Webster, Adam D. Bachstetter, Linda J. Van Eldik · 2013 · Alzheimer s Research & Therapy
12. Overview of Transgenic Mouse Models for Alzheimer's Disease
    Ariana Myers, Paul McGonigle · 2019 · Current Protocols in Neuroscience
13. Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity
    Inhee Mook‐Jung, Jieun Shin, Sung Hwan Yun, Kyoon Huh, Jae Young Koh, Hyung Keun Park, Sang‐sup Jew, Min Whan Jung · 1999 · Journal of Neuroscience Research
14. Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid
    Takaomi C. Saido · 1998 · Neurobiology of Aging
15. Neurodegenerative Tauopathies
    Virginia M.‐Y. Lee, John Q. Trojanowski · 1999 · Neuron
16. Current Concepts in the Pathogenesis of Alzheimer’s Disease
    David B. Carr, Alison Goate, D. Phil, John C. Morris · 1997 · The American Journal of Medicine
17. BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo
    Lee, Edward B., Zhang, Bin, Liu, Kangning, Greenbaum, Eric A., Doms, Robert W., Trojanowski, John Q., Lee, Virginia M.-Y. · 2005 · The Journal of Cell Biology
18. Current and emerging avenues for Alzheimer's disease drug targets
    Raúl Loera‐Valencia, Ángel Cedazo-Mínguez, Paul-Ariel Kenigsberg, Guylène Page, Ana Isabel Duarte, Pietro Giusti, Morena Zusso, Philippe Henri Robert, Giovanni Battista Frisoni, Annamaria Cattaneo et al. · 2019 · Journal of Internal Medicine
19. Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins
    Chihiro Tohda, Noriaki Matsumoto, Kun Zou, Meselhy R. Meselhy, Katsuko Komatsu · 2003 · Neuropsychopharmacology
20. The Low Density Lipoprotein Receptor Regulates the Level of CentralNervous System Human and Murine Apolipoprotein E but Does Not Modify AmyloidPlaque Pathology in PDAPPMice
    Fryer, John D., DeMattos, Ronald B., McCormick, Lynn M., O'Dell, Mark A., Spinner, Michael L., Bales, Kelly R., Paul, Steven M., Sullivan, Patrick M., Parsadanian, Maia, Bu, Guojun et al. · 2005 · Journal of Biological Chemistry
21. Alzheimer’s disease: a dysfunction of the amyloid precursor protein11Published on the World Wide Web on 11 September 2000.
    Rachael L. Neve, Donna L. McPhie, Yuzhi Chen · 2000 · Brain Research
22. Measurement of Gelatinase B (MMP-9) in the Cerebrospinal Fluid of Patients With Vascular Dementia and Alzheimer Disease
    John C. Adair, Julius Charlie, John E. Dencoff, Jeffrey Alan Kaye, Joseph F. Quinn, Richard M. Camicioli, William George Stetler‐Stevenson, Gary A. Rosenberg · 2004 · Stroke
23. Marked increase of ?-amyloid(1?42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury
    Annika Olsson, Ludvig Z. Csajbok, Martin �st, Kina H�glund, Karin Nyl�n, Lars Rosengren, Bengt Nellg�rd, Kaj Blennow · 2004 · Journal of Neurology
24. Interaction of Nascent ApoE2, ApoE3, and ApoE4 Isoforms Expressed in Mammalian Cells with Amyloid Peptide β (1−40). Relevance to Alzheimer's Disease
    Aleshkov, Sergei, Abraham, Carmela R., Zannis, Vassilis I. · 1997 · Biochemistry
25. Intracellular and secreted Alzheimer β-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons
    Pentti J. Tienari, Nobuo Ida, Elina Ikonen, Mikael Simons, Andreas Weidemann, Gerd Multhaup, Colin Louis Masters, Carlos G. Dotti, Konrad T. Beyreuther · 1997 · Proceedings of the National Academy of Sciences
26. α-1-Antichymotrypsin Promotes β-Sheet Amyloid Plaque Deposition in a Transgenic Mouse Model of Alzheimer's Disease
    Nilsson, Lars N. G., Bales, Kelly R., DiCarlo, Giovanni, Gordon, Marcia N., Morgan, Dave, Paul, Steven M., Potter, Huntington · 2001 · The Journal of Neuroscience
27. Twenty years of Alzheimer’s disease‐causing mutations
    Alison Goate, John Hardy · 2011 · Journal of Neurochemistry
28. Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
    Diana W. Shineman, Guriqbal S. Basi, Jennifer L. Bizon, Carol A. Colton, Barry Greenberg, Beth A. Hollister, John M. Lincecum, Gabrielle G. Leblanc, Linda H Lee, Feng Roger Luo et al. · 2011 · Alzheimer s Research & Therapy
29. In Vivo Effects of ApoE and Clusterin on Amyloid-β Metabolism and Neuropathology
    David M. Holtzman · 2004 · Journal of Molecular Neuroscience
30. Neuregulin-1 and ErbB4 Immunoreactivity Is Associated with Neuritic Plaques in Alzheimer Disease Brain and in a Transgenic Model of Alzheimer Disease
    Abhik Ray Chaudhury, Kimberly M. Gerecke, James Michael Wyss, David Morgan, Marcia N. Gordon, Steven Lewis Carroll · 2003 · Journal of Neuropathology & Experimental Neurology
31. Single and multiple transgenic mice as models for Alzheimer's disease
    Fred VAN LEUVEN · 2000 · Progress in Neurobiology
32. Histochemically Reactive Zinc in Plaques of the Swedish Mutant β-Amyloid Precursor Protein Transgenic Mice
    Joo‐Yong Lee, Inhee Mook‐Jung, Jae‐Young Koh · 1999 · Journal of Neuroscience
33. X11 Interaction with β-Amyloid Precursor Protein Modulates Its Cellular Stabilization and Reduces Amyloid β-Protein Secretion
    Magdalena Sastre, Raymond Scott Turner, Efrat Levy · 1998 · Journal of Biological Chemistry
34. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice
    Rachel Beeri, Christian Robert Andres, Efrat Lev-Lehman, Rina Timberg, Tamir Huberman, Moshe Shani, Hermona Soreq · 1995 · Current Biology
35. Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
    Boche, Delphine, Denham, Nathan, Holmes, Clive, Nicoll, James A. R. · 2010 · Acta Neuropathologica
36. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease
    Perdita L. Pugh, Jill C. Richardson, Simon T. Bate, Neil Upton, David Sunter · 2007 · Behavioural Brain Research
37. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer’s disease
    Elisa Ognibene, Silvia Middei, Stefania Daniele, Walter Adriani, Orlando Ghirardi, Antonio Caprioli, Giovanni Laviola · 2004 · Behavioural Brain Research
38. Peptidergic transmission: From morphological correlates to functional implications
    Günther K. H. Zupanc · 1996 · Micron
39. Inflammation occurs early during the Aβ deposition process in TgCRND8 mice
    Sherri Dudal, Pascale Krzywkowski, Julie Paquette, Céline Morissette, Diane Lacombe, Patrick Tremblay, Francine Gervais · 2004 · Neurobiology of Aging
40. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain.
    Pedersen, W A, Kloczewiak, M A, Blusztajn, J K · 1996 · Proceedings of the National Academy of Sciences
41. The “Nonamyloidogenic” p3 Fragment (Amyloid β17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid
    Maciej M. Lalowski, Adam A. Golabek, Cynthia Ann Lemere, Dennis J. Selkoe, Henryk M. Wı́sniewski, Ronald C. Beavis, Blas Frangione, Thomas Wısnıewskı · 1996 · Journal of Biological Chemistry
42. Tau and Axonopathy in Neurodegenerative Disorders
    Higuchi, Makoto, Lee, Virginia M-Y, Trojanowski, John Q · 2002 · NeuroMolecular Medicine
43. Presenilin-1 P264L Knock-In Mutation: Differential Effects on Aβ Production, Amyloid Deposition, and Neuronal Vulnerability
    Siman, Robert, Reaume, Andrew G., Savage, Mary J., Trusko, Stephen, Lin, Yin-Guo, Scott, Richard W., Flood, Dorothy G. · 2000 · The Journal of Neuroscience
44. Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice
    Schroeter, S., Khan, K., Barbour, R., Doan, M., Chen, M., Guido, T., Gill, D., Basi, G., Schenk, D., Seubert, P. et al. · 2008 · Journal of Neuroscience
45. Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein
    Zerbinatti, Celina V., Wozniak, David F., Cirrito, John, Cam, Judy A., Osaka, Hiroshi, Bales, Kelly R., Zhuo, Min, Paul, Steven M., Holtzman, David M., Bu, Guojun · 2004 · Proceedings of the National Academy of Sciences
46. Oligodendrocytes and Alzheimer's disease
    Zhiyou Cai, Ming Xiao · 2015 · International Journal of Neuroscience
47. Spines, plasticity, and cognition in Alzheimer's model mice
    Spires-Jones, Tara, Knafo, Shira · 2012 · Neural Plasticity
48. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model
    Xiaorui Cheng, Wenxia Zhou, Yongxiang Zhang · 2013 · Ageing Research Reviews
49. Extracellular amyloid formation and associated pathology in neural grafts
    Melanie Meyer‐Luehmann, Martina Stalder, Martin C. Herzig, Stephan A. Kaeser, Esther Kohler, Michelle Pfeifer, Sonia Boncristiano, Paul M. Mathews, Marc H. Mercken, Dorothée Abramowski et al. · 2003 · Nature Neuroscience
50. Animal models of Alzheimer disease: historical pitfalls and a path forward
    Cavanaugh, Sarah E. · 2014 · ALTEX
51. Curcumin improves learning and memory ability and its neuroprotective mechanism in mice
    Rui Le Pan, Sheng Qiu, Daxiang Lu, Jun Dong · 2008 · Chinese Medical Journal
52. Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
    Annika Olsson, Kina Höglund, Magnus J.C. Sjögren, Niels Andreasen, Lennart Minthon, Lars Lannfelt, Katharina Büerger, Hans‐Jürgen Möller, Harald Juergen Hampel, Pia Davidsson et al. · 2003 · Experimental Neurology
53. Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau–A Deleterious Trio
    Karen Schmitt, Amandine Grimm, Anna Wilkaniec, Joanna Benigna Strosznajder, Jürgen Götz, Anne Eckert · 2011 · Antioxidants and Redox Signaling
54. Engineering large animal models of human disease
    Bruce Whitelaw, Timothy P. Sheets, Simon Geoffrey Lillico, Bhanu Prakash V. L. Telugu · 2015 · The Journal of Pathology
55. Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formation
    David R Howlett, Ashley R. George, Davina E. OWEN, Robin V. Ward, Roger E. Markwell · 1999 · Biochemical Journal
56. Deposition of Monomeric, Not Oligomeric, Aβ Mediates Growth of Alzheimer's Disease Amyloid Plaques in Human Brain Preparations
    Bertrand P. Tseng, William P. Esler, Clary B. Clish, Evelyn R. Stimson, Joseph R. Ghilardi, Harry V. Vinters, Patrick W. Mantyh, Jonathan P. Lee, John E. Maggio · 1999 · Biochemistry
57. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation
    Irene Han-Juo Cheng, Jorge J. Palop, Luke Esposito, Nga Bien‐Ly, Fengrong Yan, Lennart Mucke · 2004 · Nature Medicine
58. Paired helical filament-like phosphorylation of tau, deposition of β/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A
    Thomas Arendt, Max Holzer, R. Fruth, Martina K. Brückner, Ulrich Gärtner · 1995 · Neuroscience
59. Cell-specific expression of β-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes
    H.A Rohan de Silva, Angela Jen, Colin Wickenden, Ling‐Sun Jen, Sarah L Wilkinson, Ambrish J. Patel · 1997 · Molecular Brain Research
60. FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction
    Flood, D · 2002 · Neurobiology of Aging
61. A plasticity-based theory of the pathogenesis of Alzheimer's disease.
    MESULAM, M.‐MARSEL · 2000 · Annals of the New York Academy of Sciences
62. Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
    Raquel Maria Sanchez-Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, Cristina Nuñez‐Diaz, Laura Cáceres-Palomo, Laura Vegas‐Gomez, Elisabeth Sánchez‐Mejías, Laura Trujillo‐Estrada, Juan Antonio García‐León, Inés Moreno‐González et al. · 2022 · International Journal of Molecular Sciences
63. Upregulation of Amyloid Precursor Protein Messenger RNA in Response to Traumatic Brain Injury: An Ovine Head Impact Model
    Corinna van den Heuvel, Peter Charles Blumbergs, John W Finnie, Jim Manavis, Nigel R. Jones, Peter Lawrence Reilly, Rosemarie A. Pereira · 1999 · Experimental Neurology
64. Neuroanatomical Abnormalities in Behaviorally Characterized APPV717F Transgenic Mice
    Jean‐Cosme Dodart, Chantal Mathis, Josep Saura, Kelly R. Bales, Steven M. Paul, Arielle Ungerer · 2000 · Neurobiology of Disease
65. Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Aβ42 Accumulation in Amyloid Model Mice
    Zerbinatti, Celina V., Wahrle, Suzanne E., Kim, Hyungjin, Cam, Judy A., Bales, Kelly, Paul, Steven M., Holtzman, David M., Bu, Guojun · 2006 · Journal of Biological Chemistry
66. Amyloid β-peptide and oxidative cellular injury in Alzheimer’s disease
    Robert J. Mark, Emmanuelle M. Blanc, Mark P. Mattson · 1996 · Molecular Neurobiology
67. Altered metabolism of familial Alzheimer's disease-linked amyloid precursor protein variants in yeast artificial chromosome transgenic mice
    Lamb, B. · 1997 · Human Molecular Genetics
68. Amyloid-β deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition
    Changiz Geula, Nicholas G. Nagykery, Chuang‐Kuo Wu · 2001 · Acta Neuropathologica
69. Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
    Nehra, Geetika, Bauer, Bjoern, Hartz, Anika M.S. · 2022 · Pharmacology & Therapeutics
70. Molecular toxicity of aluminium in relation to neurodegeneration.
    P Vasudevaraju, M Govindaraju, A P Palanisamy, K Sambamurti, K. S. Jagannatha Rao · 2008 · PubMed
71. Cholinergic activity and amyloid precursor protein metabolism
    Melinda R Roberson · 1997 · Brain Research Reviews
72. Obesity, leptin, and Alzheimer's disease
    Lee, Edward B. · 2011 · Annals of the New York Academy of Sciences
73. Targeting innate immunity for neurodegenerative disorders of the central nervous system
    Andreasson, Katrin I., Bachstetter, Adam D., Colonna, Marco, Ginhoux, Florent, Holmes, Clive, Lamb, Bruce, Landreth, Gary, Lee, Daniel C., Low, Donovan, Lynch, Marina A. et al. · 2016 · Journal of Neurochemistry
74. Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease
    Hurtado, David E., Molina-Porcel, Laura, Carroll, Jenna C., MacDonald, Caryn, Aboagye, Awo K., Trojanowski, John Q., Lee, Virginia M.-Y. · 2012 · The Journal of Neuroscience
75. Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity
    Kevin Mullane, Michael J. Williams · 2019 · Current Protocols in Pharmacology
76. Divergent roles of GSK3 and CDK5 in APP processing
    John W. Ryder, Su Yuan, Feng Liu, Baolin Li, Yan Zhou, Binhui Ni · 2003 · Biochemical and Biophysical Research Communications
77. Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice
    Wirths, Oliver, Multhaup, Gerd, Czech, Christian, Feldmann, Nicole, Blanchard, Véronique, Tremp, Günter, Beyreuther, Konrad, Pradier, Laurent, Bayer, Thomas A. · 2002 · Brain Pathology
78. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model
    Yingxin Yu, Jue He, Yanbo Zhang, Huanmin Luo, Shenghua Zhu, Yi Yang, Tou Zhao, Jiang Wu, Yuan‐Gui Huang, Jiming Kong et al. · 2009 · Hippocampus
79. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice
    Thomas L. Kukar, Sonya Prescott, Jason L. Eriksen, Vallie M. Holloway, Michael Paul Murphy, Edward H. Koo, Todd Eliot Golde, Michelle M. Nicolle · 2007 · BMC Neuroscience
80. Does my mouse have Alzheimer's disease?
    Jean‐Cosme Dodart, Chantal Mathis, Kelly R. Bales, Steven M. Paul · 2002 · Genes Brain & Behavior
81. Protein misfolding in neurodegenerative diseases
    Eleftherios I. Agorogiannis, G. I. Agorogiannis, Alexandros Papadimitriou, George M. Hadjigeorgiou · 2004 · Neuropathology and Applied Neurobiology
82. Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits
    Sally Ann Frautschy, Fusheng Yang, Leticia Calderón, Greg M. Cole · 1996 · Neurobiology of Aging
83. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein
    Gomes, Luis Aragão, Hipp, Silvia Andrea, Rijal Upadhaya, Ajeet, Balakrishnan, Karthikeyan, Ospitalieri, Simona, Koper, Marta J., Largo-Barrientos, Pablo, Uytterhoeven, Valerie, Reichwald, Julia, Rabe, Sabine et al. · 2019 · Acta Neuropathologica
84. Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis
    Sheng, Jin G., Price, Donald L., Koliatsos, Vassilis E. · 2002 · The Journal of Neuroscience
85. Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria
    Judie R. Walton · 2014 · Journal of Alzheimer s Disease
86. Behavioural analysis and susceptibility to CNS injury of four inbred strains of mice
    Stephen Royle, Fiona C Collins, H. Thomas Rupniak, Julie C. Barnes, Richard Anderson · 1999 · Brain Research
87. Aβ25–35 induces rapid lysis of red blood cells: contrast with Aβ1–42 and examination of underlying mechanisms
    Mark P. Mattson, James G. Begley, Robert J. Mark, Katsutoshi Furukawa · 1997 · Brain Research
88. Human-like rodent amyloid-β-peptide determines Alzheimer pathology in aged wild-type Octodon degu
    Nibaldo C. Inestrosa, Ariel E. Reyes, Marcelo A. Chacón, Waldo F. Cerpa, Aldo Villalón, Juan F. Montiel, Genevieve Merabachvili, Rebeca Aldunate, Francisco Bozinovic, Francisco Aboitiz · 2004 · Neurobiology of Aging
89. Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life
    Ganesh M. Shankar, Malcolm A. Leissring, Anthony Adame, Xiaoyan Sun, Edward Spooner, Eliezer Masliah, Dennis J. Selkoe, Cynthia Ann Lemere, Dominic M. Walsh · 2009 · Neurobiology of Disease
90. Hybrid FMT–CT imaging of amyloid-β plaques in a murine Alzheimer's disease model
    Damon E. Hyde, R DEKLEINE, Sarah A. MacLaurin, Eric L. Miller, D BROOKS, Thomas Krucker, Vasilis Ntziachristos · 2008 · NeuroImage
91. Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments
    Scott P. Fraser, Y-H Suh, Mustafa B. A. Djamgoz · 1997 · Trends in Neurosciences
92. Smart optical probes for near-infrared fluorescence imaging of Alzheimer’s disease pathology
    Scott B. Raymond, Jesse M. Skoch, Ivory D. Hills, Evgueni E. Nesterov, Timothy M. Swager, Brian J. Bacskai · 2008 · European Journal of Nuclear Medicine and Molecular Imaging
93. Generation and Regulation of β‐Amyloid Peptide Variants by Neurons
    Gunnar K. Gouras, Huaxi Xu, Jasmina N. Jovanovic, Joseph D. Buxbaum, Rong Wang, Paul Greengard, Norman R. Relkin, Sam Gandy · 1998 · Journal of Neurochemistry
94. Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression
    Saito, Takashi, Matsuba, Yukio, Yamazaki, Naomi, Hashimoto, Shoko, Saido, Takaomi C. · 2016 · The Journal of Neuroscience
95. Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A antibody
    Kelly R. Bales · 2006 · Journal of Clinical Investigation
96. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
    Claudia Schwab, Masato Hosokawa, Patrick L. McGeer · 2004 · Experimental Neurology
97. Age-independent and age-related deficits in visuospatial learning, sleep–wake states, thermoregulation and motor activity in PDAPP mice
    Salvador Huitrón‐Reséndiz, Manuel Sánchez-Alavez, Roger A. Gallegos, Greta I. Berg, Elena F. Crawford, J.L. Giacchino, Dora Games, Steven J. Henriksen, José R. Criado · 2002 · Brain Research
98. A small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model
    Juliet K. Knowles, Danielle A. Simmons, Thuy‐Vi V. Nguyen, Lilith Vander Griend, Youmei Xie, Hong Zhang, Tao Yang, Julia Pollak, Timothy Chang, Ottavio Arancio et al. · 2013 · Neurobiology of Aging
99. Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons
    Theresa A. Good, Dean O. Smith, Regina M. Murphy · 1996 · Biophysical Journal
100. Neuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
     Qiao, Xiaoxi, Cummins, David J., Paul, Steven M. · 2001 · European Journal of Neuroscience